CaixaBank, S.A.
CaixaBank, S.A. (CAIXY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for CaixaBank, S.A. (CAIXY), featuring income statements, balance sheets, and cash flow data.
CaixaBank, S.A. (CAIXY) Income Statement & Financial Overview
Analyze CaixaBank, S.A.’s CAIXY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.04B | $4.12B | $6.57B | $6.72B |
| Cost of Revenue | $0.00 | $0.00 | $5.02B | $0.00 |
| Gross Profit | $4.04B | $4.12B | $1.55B | $6.72B |
| Gross Profit Ratio | $1.00 | $1.00 | $0.24 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $407.00M | $389.00M | $388.00M | $388.00M |
| Operating Expenses | $1.73B | $1.69B | $4.05B | $459.00M |
| Total Costs & Expenses | $1.73B | $1.69B | $4.05B | $4.42B |
| Interest Income | $2.65B | $2.74B | $2.79B | $2.79B |
| Interest Expense | $0.00 | $0.00 | $0.00 | $693.00M |
| Depreciation & Amortization | $192.00M | $192.00M | $196.00M | $194.00M |
| EBITDA | $0.00 | $0.00 | $2.31B | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.35 | $0.00 |
| Operating Income | $2.31B | $2.43B | $2.31B | $64.00M |
| Operating Income Ratio | $0.57 | $0.59 | $0.35 | $0.010 |
| Other Income/Expenses (Net) | -$129.00M | -$265.00M | -$93.00M | $433.00M |
| Income Before Tax | $2.19B | $2.17B | $2.21B | $2.25B |
| Income Before Tax Ratio | $0.54 | $0.53 | $0.34 | $0.34 |
| Income Tax Expense | $715.00M | $624.00M | $639.00M | $648.00M |
| Net Income | $1.47B | $1.54B | $1.57B | $1.67B |
| Net Income Ratio | $0.36 | $0.37 | $0.24 | $0.25 |
| EPS | $0.21 | $0.22 | $0.22 | $0.23 |
| Diluted EPS | $0.21 | $0.22 | $0.22 | $0.23 |
| Weighted Avg Shares Outstanding | $7.12B | $7.12B | $7.22B | $7.26B |
| Weighted Avg Shares Outstanding (Diluted) | $7.12B | $7.12B | $7.22B | $7.26B |
The company's financials show resilient growth, with revenue advancing from $6.72B in Q2 2024 to $4.04B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $2.31B last quarter, sustaining a consistent 57% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income dropped to $1.47B, while earnings per share reached $0.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan